Trial intelligence / Profile preview

Allopurinol for Fructose-Induced Metabolic Syndrome

NCT00639756Phase 2Completed

Sponsor
Hospital Mateu Orfila
Start
Jun 2008
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of allopurinol in metabolic syndrome, sponsored by Hospital Mateu Orfila. Started Jun 2008; status: completed.

02

Drugs

allopurinol
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT00639756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00639756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call